Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Microbix Biosystems Inc T.MBX

Alternate Symbol(s):  MBXBF

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.


TSX:MBX - Post by User

Comment by Mbxwatcheron Mar 17, 2021 10:42am
133 Views
Post# 32815961

RE:RE:majority of announcements past year

RE:RE:majority of announcements past yearJan 28th: Microbix is currently in discussions with Plexxus, a leading supply-chain organization that supports hospitals in Ontario, to procure DxTM for testing programs within the province. Any supply of DxTM not procured by Plexxus or other representatives of the Government of Ontario will be made available on a first-come-first-served basis – including to other provinces and private testing organizations."

March 17th......no update on these discussions for a product that was so important to the province that they invested 1.5 million dollars in MBX.      All we have is faith to go on that we are even selling any VTM right now.....   

The one announcement that moved the needle more last year than any other was the announcement that MBX had won funding for VTM.    In my opinion this clarification is the whole ballgame in the short term............

This was a pattern with MBX in the past.  Get shareholders excited about a prospect, and then it slowly just disappears..  I am not saying this with VTM, but Kinlytic is a perfect example of a Home run prospect that never gets updated.    

Credibility matters.....are we actually selling to other parties if not Plexxus.......I think this continues to slowly slide until this answer is known.
<< Previous
Bullboard Posts
Next >>